Home Healthcare Biotechnology Blood Cancer Diagnostics Market

Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Blood tests., Biopsy, Imaging tests, Molecular tests), By Product (Instruments, Assay kits & reagents), By End-User (Hospitals, Specialty clinics, Diagnostic Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Blood Cancer Diagnostics Market, By Test Type 2022-2034 (USD MILLION/ Units)
    1. Blood tests.
    2. Biopsy
    3. Imaging tests
    4. Molecular tests
  2. Blood Cancer Diagnostics Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Instruments
    2. Assay kits & reagents
  3. Blood Cancer Diagnostics Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Specialty clinics
    3. Diagnostic Centers
    4. Others
  4. Regional Blood Cancer Diagnostics Market
    1. North America
      1. North America Blood Cancer Diagnostics Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
      2. North America Blood Cancer Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay kits & reagents
      3. North America Blood Cancer Diagnostics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty clinics
        3. Diagnostic Centers
        4. Others
      4. U.S.
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      5. Canada
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
    2. Europe
      1. Europe Blood Cancer Diagnostics Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
      2. Europe Blood Cancer Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay kits & reagents
      3. Europe Blood Cancer Diagnostics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty clinics
        3. Diagnostic Centers
        4. Others
      4. U.K.
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      5. Germany
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      6. France
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      7. Spain
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      8. Italy
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      9. Russia
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      10. Nordic
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      11. Benelux
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      12. Rest of Europe
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
    3. APAC
      1. APAC Blood Cancer Diagnostics Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
      2. APAC Blood Cancer Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay kits & reagents
      3. APAC Blood Cancer Diagnostics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty clinics
        3. Diagnostic Centers
        4. Others
      4. China
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      5. Korea
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      6. Japan
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      7. India
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      8. Australia
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      9. Taiwan
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      10. South East Asia
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      11. Rest of Asia-Pacific
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
    4. Middle East and Africa
      1. Middle East and Africa Blood Cancer Diagnostics Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
      2. Middle East and Africa Blood Cancer Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay kits & reagents
      3. Middle East and Africa Blood Cancer Diagnostics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty clinics
        3. Diagnostic Centers
        4. Others
      4. UAE
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      5. Turkey
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      6. Saudi Arabia
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      7. South Africa
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      8. Egypt
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      9. Nigeria
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      10. Rest of MEA
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
    5. LATAM
      1. LATAM Blood Cancer Diagnostics Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
      2. LATAM Blood Cancer Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay kits & reagents
      3. LATAM Blood Cancer Diagnostics Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty clinics
        3. Diagnostic Centers
        4. Others
      4. Brazil
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      5. Mexico
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      6. Argentina
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      7. Chile
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      8. Colombia
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
      9. Rest of LATAM
        1. Blood tests.
        2. Biopsy
        3. Imaging tests
        4. Molecular tests
        5. Instruments
        6. Assay kits & reagents
        7. Hospitals
        8. Specialty clinics
        9. Diagnostic Centers
        10. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.